发明名称 |
Anti-ILT7 Antibody |
摘要 |
Abstract An antibody binding to IPC was obtained by using an animal cell in which a cell membrane protein associatable with ILT7 was co-expressed as an immunogen. The antibody of the invention has a high specificity which allows immunological distinction between other ILT family molecules and ILT7. The anti-ILT7 antibody of the invention bound to IPC and inhibited the activity thereof. With the anti:-ILT7 antibody of the invention, the IPC activity can be inhibited and an interferon-related disease can be treated or prevented. ILT7 expression is maintained even in IPC in the presence of IFN. Thereforer an inhibitory action of IPC activity by the anti-ILT7 antibody can be expected even in an autoimmune. disease patient with an increased production of IFNa. |
申请公布号 |
AU2014265023(A1) |
申请公布日期 |
2014.12.04 |
申请号 |
AU20140265023 |
申请日期 |
2014.11.18 |
申请人 |
SBI BIOTECH CO, LTD. |
发明人 |
KAMOGAWA, YUMIKO;ARAI, NAOKO;ISHIDA, KOJI;CHO, MINKWON |
分类号 |
C07K16/28;A61K39/395;A61K48/00;A61P17/06;A61P31/18;A61P35/00;A61P37/02;A61P43/00;C12N5/10;C12N15/09;C12P21/08;G01N33/53;G01N33/577 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|